Imagine rush-hour traffic. Vehicles inching forward, horns blaring, and signals failing to keep pace. Now replace cars with glucose molecules after a meal, and you have a glimpse of how our body struggles in type 2 diabetes. Under normal conditions, glucose flows smoothly into pancreatic cells, triggering insulin release to balance blood sugar. But when this system falters, it leads to a dangerous metabolic traffic jam.
The IISc Discovery
A team of researchers at the Indian Institute of Science (IISc), Bengaluru, led by Dr. Nikhil Gandasi, Assistant Professor in the Department of Developmental Biology and Genetics, has uncovered why this breakdown happens. Their findings, published in the Proceedings of the National Academy of Sciences (PNAS), open new possibilities for diabetes treatment.
Gatekeepers at the Cellular Level
Normally, special proteins called glucose transporters (GLUTs) act as gatekeepers. When blood sugar rises, these proteins rush to the surface of pancreatic cells, forming quick entryways for glucose. Once inside, glucose triggers insulin release, allowing the body to use or store sugar effectively.
In type 2 diabetes, however, this gatekeeping system malfunctions. Fewer GLUTs reach the cell surface, and their back-and-forth movement slows dramatically. The result? Glucose remains stuck outside, and insulin release becomes sluggish—just like a traffic jam caused by too few open lanes.
A Fresh Perspective on Diabetes Research
“Most studies have focused on what happens after glucose enters pancreatic cells,” explained Anuma Pallavi, PhD student and first author of the study. “We examined the step before that—the entry of glucose itself—and found how this process is disrupted in diabetes,” Pallavi added. This new lens suggests potential intervention points to improve beta-cell function. While most existing diabetes drugs focus on making insulin work better in muscles and fat, targeting glucose entry into the pancreas itself could help slow disease progression.
Towards Future Therapies
Interestingly, Gandasi’s lab had earlier shown that Pheophorbide A, a plant-based molecule, can enhance insulin release by interacting with glucose transporters. This raises hope for novel therapies aimed at restoring GLUT movement. “If we can restore proper transporter dynamics inside cells, we may be able to not only slow diabetes progression but also personalise treatments for patients,” said Dr. Gandasi.
What This Means for Patients
As reported by thesouthfirst.com, for millions of people living with diabetes, this research offers new hope. By addressing the root of the problem—glucose getting stuck outside cells—future therapies may provide smoother blood sugar control, much like easing traffic congestion on city roads.